Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).

Oliver DörrClaudia WaltherChristoph LiebetrauTill KellerRegine M OrtliebNiklas F BoederPascal BauerHelge MöllmannLuise GaedeChristian TroidlSandra VossTimm BauerChristian W HammHolger Nef

Published in: Clinical cardiology (2018)

Cystatin C and urinary NGAL were found to be predictors of long-term mortality in high-risk patients undergoing PMVR. Thus, cystatin C and NGAL assessment may be helpful in risk stratification in patients undergoing PMVR.

Keyphrases

patients undergoing
cardiovascular events
mitral valve
cardiovascular disease
type diabetes
radiofrequency ablation